Cargando…
Evaluation of the safety and efficacy of extracorporeal carbon dioxide removal in the critically ill using the PrismaLung+ device
BACKGROUND: Several extracorporeal carbon dioxide removal (ECCO(2)R) devices are currently in use with variable efficacy and safety profiles. PrismaLung+ is an ECCO(2)R device that was recently introduced into clinical practice. It is a minimally invasive, low flow device that provides partial respi...
Autores principales: | Tiruvoipati, Ravindranath, Ludski, Jarryd, Gupta, Sachin, Subramaniam, Ashwin, Ponnapa Reddy, Mallikarjuna, Paul, Eldho, Haji, Kavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436516/ https://www.ncbi.nlm.nih.gov/pubmed/37596670 http://dx.doi.org/10.1186/s40001-023-01269-2 |
Ejemplares similares
-
In vitro characterization of PrismaLung+: a novel ECCO(2)R device
por: Hospach, Ingeborg, et al.
Publicado: (2020) -
COVID-19 Is Not Comparable to H1N1 Influenza
por: Tiruvoipati, Ravindranath, et al.
Publicado: (2022) -
Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature
por: Haji, Kavi, et al.
Publicado: (2021) -
Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor
por: Banakh, Iouri, et al.
Publicado: (2017) -
Improving Sleep in Intensive Care Unit: An Overview of Diagnostic and Therapeutic Options
por: Tiruvoipati, Ravindranath, et al.
Publicado: (2019)